Back
Results - Announcements
Sales decline 37.50% to Rs 0.05 crore
Transgene Biotek reports consolidated net loss of Rs 0.46 crore in the March 2026 quarter
30-May-2026, 09:22
Net Loss of Transgene Biotek reported to Rs 0.46 crore in the quarter ended March 2026 as against net loss of Rs 0.71 crore during the previous quarter ended March 2025. Sales declined 37.50% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025.
Net Loss of Transgene Biotek reported to Rs 0.46 crore in the quarter ended March 2026 as against net loss of Rs 0.71 crore during the previous quarter ended March 2025. Sales declined 37.50% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 1.65 crore in the year ended March 2026 as against net loss of Rs 0.68 crore during the previous year ended March 2025. Sales declined 19.23% to Rs 0.21 crore in the year ended March 2026 as against Rs 0.26 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 0.05 | 0.08 | -38 | 0.21 | 0.26 | -19 |
| OPM % | -560.00 | -675.00 | - | -257.14 | -430.77 | - |
| PBDT | -0.41 | -0.69 | 41 | -1.45 | -0.58 | -150 |
| PBT | -0.46 | -0.71 | 35 | -1.65 | -0.68 | -143 |
| NP | -0.46 | -0.71 | 35 | -1.65 | -0.68 | -143 |
Powered by Capital Market - Live News